A revolutionary approach to non-surgical permanent contraceptions
Safe
Demonstrated safety from clinical trials were consistent with those typically observed for intrauterine transcervical procedures, with no on-going safety concerns through five years.1
No reports of serious adverse events (n=0/229).1
Most common non-serious adverse events reported were spotting/bleeding and/or pelvic pain/cramps that usually resolved shortly after the procedure.1
Effective
0% pregnancy rate with FemBloc1, providing compelling evidence of effectiveness.
Significantly lower than historic surgical sterilization (5.7% pregnancy rate for surgical (laparoscopic) sterilization).2
Confirmation test after FemBloc confirms procedure success before patient relies on FemBloc for permanent contraception
Accessible
Time-saving option for permanent contraception since the procedure is performed quickly with no surgery.
No recovery downtime, resume normal activities immediately.
Affordable
FemBloc is a cost-effective option to offer patients no longer intending children.
FemBloc allows for expanded practice services with a non-surgical, minimally invasive permanent contraceptive option.
1Liu, J. H., Blumenthal, P. D., Castano, P. M., Chudnoff, S. C., Gawron, L. M., Johnstone, E. B., Lee-Sepsick, K. (2025). FemBloc Non-Surgical Permanent Contraception for Occlusion of the Fallopian Tubes. J Gynecol Reprod Med, 9(1), 01-12. doi: 10.33140/JGRM.09.01.05.
2Gariepy AM, Lewis C, Zuckerman D, et al. Comparative Effectiveness of Hysteroscopic and Laparoscopic Sterilization for Women: A Retrospective Cohort Study. Fertility and Sterility, 2022, 117(6):1322-1331. doi: 10.1016/j.fertnstert.2022.03.001.
FemBloc is designed to achieve permanent contraception by delivering our proprietary blended polymer into the fallopian tubes without surgery. After a natural healing response, nonfunctional scar tissue in a small section of each fallopian tube remains for bilateral occlusion.
FemBloc Benefits include: